CareDx's CEO Sells 17K Shares
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last?
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overvalued
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans
CareDx, Inc. (CDNA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Baron Discovery Fund Q1 2026: Who Moved The Needle
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies
CareDx to Participate in Upcoming Investor Conferences
CareDx Announces Dismissal of 2021 Qui Tam Suit
CareDx, Inc. (CDNA) Q1 2026 Earnings Call Transcript
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx (CDNA) Q1 Earnings and Revenues Top Estimates
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
CareDx Announces First Quarter 2026 Financial Results
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation's 46th Annual Meeting
CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA Typing
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
All You Need to Know About CareDx (CDNA) Rating Upgrade to Buy
CareDx Sharpens Focus On Core Testing Services
Eurobio scientific signs definitive agreement to acquire CareDx's transplant Lab Product division
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
Bamco Inc. NY Has $45.88 Million Stake in CareDx, Inc. $CDNA
CareDx Introduces VANTx AI Platform for Complex Transplant Datasets
CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (CDNA) Q4 2025 Earnings Call Transcript
CareDx (CDNA) Reports Q4 Earnings: What Key Metrics Have to Say
CareDx (CDNA) Q4 Earnings Miss Estimates
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results
Comparing CareDx (NASDAQ:CDNA) and Elevance Health (NYSE:ELV)
Thrivent Financial for Lutherans Cuts Holdings in CareDx, Inc. $CDNA
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference
CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT
Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells
CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026
CareDx President and CEO Sells 19,000 Shares for $412,000
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
CareDx (NASDAQ:CDNA) CEO John Walter Hanna, Jr. Sells 10,156 Shares
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Recommendation of “Hold” from Analysts
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response